Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1B

Protein tyrosine phosphatase 1B (PTP1B), a negative regulator of the insulin signaling pathway, has gained attention as a validated druggable target in the management of type 2 diabetes mellitus (T2DM). The lack of clinically approved PTP1B inhibitors has continued to prompt research in plant-derive...

Full description

Saved in:
Bibliographic Details
Main Authors: Athika Rampadarath, Fatai Oladunni Balogun, Charlene Pillay, Saheed Sabiu
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2022/6233217
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549179420835840
author Athika Rampadarath
Fatai Oladunni Balogun
Charlene Pillay
Saheed Sabiu
author_facet Athika Rampadarath
Fatai Oladunni Balogun
Charlene Pillay
Saheed Sabiu
author_sort Athika Rampadarath
collection DOAJ
description Protein tyrosine phosphatase 1B (PTP1B), a negative regulator of the insulin signaling pathway, has gained attention as a validated druggable target in the management of type 2 diabetes mellitus (T2DM). The lack of clinically approved PTP1B inhibitors has continued to prompt research in plant-derived therapeutics possibly due to their relatively lesser toxicity profiles. Flavonoid C-glycosides are one of the plant-derived metabolites gaining increased relevance as antidiabetic agents, but their possible mechanism of action remains largely unknown. This study investigates the antidiabetic potential of flavonoid C-glycosides against PTP1B in silico and in vitro. Of the seven flavonoid C-glycosides docked against the enzyme, three compounds (apigenin, vitexin, and orientin) had the best affinity for the enzyme with a binding score of –7.3 kcal/mol each, relative to –7.4 kcal/mol for the reference standard, ursolic acid. A further probe (in terms of stability, flexibility, and compactness) of the complexes over a molecular dynamics time study of 100 ns for the three compounds suggested orientin as the most outstanding inhibitor of PTP1B owing to its overall -34.47 kcal/mol binding energy score compared to ursolic acid (-19.24 kcal/mol). This observation was in accordance with the in vitro evaluation result, where orientin had a half maximal inhibitory concentration (IC50) of 0.18 mg/ml relative to 0.13 mg/ml for the reference standard. The kinetics of inhibition of PTP1B by orientin was mixed-type with Vmax and Km values of 0.004 μM/s and 0.515 μM. Put together, the results suggest orientin as a potential PTP1B inhibitor and could therefore be further explored in the management T2DM as a promising therapeutic agent.
format Article
id doaj-art-90d352ba19704c34ac0d5761b44f972f
institution Kabale University
issn 2314-6753
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-90d352ba19704c34ac0d5761b44f972f2025-02-03T06:11:55ZengWileyJournal of Diabetes Research2314-67532022-01-01202210.1155/2022/6233217Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1BAthika Rampadarath0Fatai Oladunni Balogun1Charlene Pillay2Saheed Sabiu3Department of Biotechnology and Food ScienceDepartment of Biotechnology and Food ScienceDepartment of Biotechnology and Food ScienceDepartment of Biotechnology and Food ScienceProtein tyrosine phosphatase 1B (PTP1B), a negative regulator of the insulin signaling pathway, has gained attention as a validated druggable target in the management of type 2 diabetes mellitus (T2DM). The lack of clinically approved PTP1B inhibitors has continued to prompt research in plant-derived therapeutics possibly due to their relatively lesser toxicity profiles. Flavonoid C-glycosides are one of the plant-derived metabolites gaining increased relevance as antidiabetic agents, but their possible mechanism of action remains largely unknown. This study investigates the antidiabetic potential of flavonoid C-glycosides against PTP1B in silico and in vitro. Of the seven flavonoid C-glycosides docked against the enzyme, three compounds (apigenin, vitexin, and orientin) had the best affinity for the enzyme with a binding score of –7.3 kcal/mol each, relative to –7.4 kcal/mol for the reference standard, ursolic acid. A further probe (in terms of stability, flexibility, and compactness) of the complexes over a molecular dynamics time study of 100 ns for the three compounds suggested orientin as the most outstanding inhibitor of PTP1B owing to its overall -34.47 kcal/mol binding energy score compared to ursolic acid (-19.24 kcal/mol). This observation was in accordance with the in vitro evaluation result, where orientin had a half maximal inhibitory concentration (IC50) of 0.18 mg/ml relative to 0.13 mg/ml for the reference standard. The kinetics of inhibition of PTP1B by orientin was mixed-type with Vmax and Km values of 0.004 μM/s and 0.515 μM. Put together, the results suggest orientin as a potential PTP1B inhibitor and could therefore be further explored in the management T2DM as a promising therapeutic agent.http://dx.doi.org/10.1155/2022/6233217
spellingShingle Athika Rampadarath
Fatai Oladunni Balogun
Charlene Pillay
Saheed Sabiu
Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1B
Journal of Diabetes Research
title Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1B
title_full Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1B
title_fullStr Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1B
title_full_unstemmed Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1B
title_short Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1B
title_sort identification of flavonoid c glycosides as promising antidiabetics targeting protein tyrosine phosphatase 1b
url http://dx.doi.org/10.1155/2022/6233217
work_keys_str_mv AT athikarampadarath identificationofflavonoidcglycosidesaspromisingantidiabeticstargetingproteintyrosinephosphatase1b
AT fataioladunnibalogun identificationofflavonoidcglycosidesaspromisingantidiabeticstargetingproteintyrosinephosphatase1b
AT charlenepillay identificationofflavonoidcglycosidesaspromisingantidiabeticstargetingproteintyrosinephosphatase1b
AT saheedsabiu identificationofflavonoidcglycosidesaspromisingantidiabeticstargetingproteintyrosinephosphatase1b